These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
162 related articles for article (PubMed ID: 12750275)
1. LAG-3 enables DNA vaccination to persistently prevent mammary carcinogenesis in HER-2/neu transgenic BALB/c mice. Cappello P; Triebel F; Iezzi M; Caorsi C; Quaglino E; Lollini PL; Amici A; Di Carlo E; Musiani P; Giovarelli M; Forni G Cancer Res; 2003 May; 63(10):2518-25. PubMed ID: 12750275 [TBL] [Abstract][Full Text] [Related]
2. DNA vaccination against rat her-2/Neu p185 more effectively inhibits carcinogenesis than transplantable carcinomas in transgenic BALB/c mice. Rovero S; Amici A; Di Carlo E; Bei R; Nanni P; Quaglino E; Porcedda P; Boggio K; Smorlesi A; Lollini PL; Landuzzi L; Colombo MP; Giovarelli M; Musiani P; Forni G J Immunol; 2000 Nov; 165(9):5133-42. PubMed ID: 11046045 [TBL] [Abstract][Full Text] [Related]
3. Combined allogeneic tumor cell vaccination and systemic interleukin 12 prevents mammary carcinogenesis in HER-2/neu transgenic mice. Nanni P; Nicoletti G; De Giovanni C; Landuzzi L; Di Carlo E; Cavallo F; Pupa SM; Rossi I; Colombo MP; Ricci C; Astolfi A; Musiani P; Forni G; Lollini PL J Exp Med; 2001 Nov; 194(9):1195-205. PubMed ID: 11696586 [TBL] [Abstract][Full Text] [Related]
4. Insertion of the DNA for the 163-171 peptide of IL1beta enables a DNA vaccine encoding p185(neu) to inhibit mammary carcinogenesis in Her-2/neu transgenic BALB/c mice. Rovero S; Boggio K; Di Carlo E; Amici A; Quaglino E; Porcedda P; Musiani P; Forni G Gene Ther; 2001 Mar; 8(6):447-52. PubMed ID: 11313823 [TBL] [Abstract][Full Text] [Related]
5. Inhibition of mammary carcinoma development in HER-2/neu transgenic mice through induction of autoimmunity by xenogeneic DNA vaccination. Pupa SM; Iezzi M; Di Carlo E; Invernizzi A; Cavallo F; Meazza R; Comes A; Ferrini S; Musiani P; Ménard S Cancer Res; 2005 Feb; 65(3):1071-8. PubMed ID: 15705909 [TBL] [Abstract][Full Text] [Related]
6. The adjuvant activity of BAT antibody enables DNA vaccination to inhibit the progression of established autochthonous Her-2/neu carcinomas in BALB/c mice. Quaglino E; Mastini C; Iezzi M; Forni G; Musiani P; Klapper LN; Hardy B; Cavallo F Vaccine; 2005 May; 23(25):3280-7. PubMed ID: 15837233 [TBL] [Abstract][Full Text] [Related]
7. Immunoprevention of HER-2/neu transgenic mammary carcinoma through an interleukin 12-engineered allogeneic cell vaccine. De Giovanni C; Nicoletti G; Landuzzi L; Astolfi A; Croci S; Comes A; Ferrini S; Meazza R; Iezzi M; Di Carlo E; Musiani P; Cavallo F; Nanni P; Lollini PL Cancer Res; 2004 Jun; 64(11):4001-9. PubMed ID: 15173014 [TBL] [Abstract][Full Text] [Related]
8. Electroporated DNA vaccine clears away multifocal mammary carcinomas in her-2/neu transgenic mice. Quaglino E; Iezzi M; Mastini C; Amici A; Pericle F; Di Carlo E; Pupa SM; De Giovanni C; Spadaro M; Curcio C; Lollini PL; Musiani P; Forni G; Cavallo F Cancer Res; 2004 Apr; 64(8):2858-64. PubMed ID: 15087404 [TBL] [Abstract][Full Text] [Related]
9. Adenovirus vaccination against neu oncogene exerts long-term protection from tumorigenesis in BALB/neuT transgenic mice. Gallo P; Dharmapuri S; Nuzzo M; Maldini D; Cipriani B; Forni G; Monaci P Int J Cancer; 2007 Feb; 120(3):574-84. PubMed ID: 17096348 [TBL] [Abstract][Full Text] [Related]
10. DNA immunization using constant-current electroporation affords long-term protection from autochthonous mammary carcinomas in cancer-prone transgenic mice. Curcio C; Khan AS; Amici A; Spadaro M; Quaglino E; Cavallo F; Forni G; Draghia-Akli R Cancer Gene Ther; 2008 Feb; 15(2):108-14. PubMed ID: 17992201 [TBL] [Abstract][Full Text] [Related]
11. Delayed tumor onset and reduced tumor growth progression after immunization with a Her-2/neu multi-peptide vaccine and IL-12 in c-neu transgenic mice. Wagner S; Jasinska J; Breiteneder H; Kundi M; Pehamberger H; Scheiner O; Zielinski CC; Wiedermann U Breast Cancer Res Treat; 2007 Nov; 106(1):29-38. PubMed ID: 17203384 [TBL] [Abstract][Full Text] [Related]
12. Xenogeneic immunization in mice using HER2 DNA delivered by an adenoviral vector. Gallo P; Dharmapuri S; Nuzzo M; Maldini D; Iezzi M; Cavallo F; Musiani P; Forni G; Monaci P Int J Cancer; 2005 Jan; 113(1):67-77. PubMed ID: 15386429 [TBL] [Abstract][Full Text] [Related]
13. Vaccination with the extracellular domain of p185neu prevents mammary tumor development in neu transgenic mice. Esserman LJ; Lopez T; Montes R; Bald LN; Fendly BM; Campbell MJ Cancer Immunol Immunother; 1999 Feb; 47(6):337-42. PubMed ID: 10203064 [TBL] [Abstract][Full Text] [Related]
14. Activity of DNA vaccines encoding self or heterologous Her-2/neu in Her-2 or neu transgenic mice. Jacob J; Radkevich O; Forni G; Zielinski J; Shim D; Jones RF; Wei WZ Cell Immunol; 2006 Apr; 240(2):96-106. PubMed ID: 16930573 [TBL] [Abstract][Full Text] [Related]
15. DNA vaccines targeting tumor antigens to B7 molecules on antigen-presenting cells induce protective antitumor immunity and delay onset of HER-2/Neu-driven mammary carcinoma. Sloots A; Mastini C; Rohrbach F; Weth R; Curcio C; Burkhardt U; Jäger E; Forni G; Cavallo F; Wels WS Clin Cancer Res; 2008 Nov; 14(21):6933-43. PubMed ID: 18980988 [TBL] [Abstract][Full Text] [Related]
16. Co-expression of Flt-3 ligand gene ablates tumor immunity elicited by HER-2/neu DNA vaccine in transgenic mice. Venanzi FM; Barucca A; Havas K; Capitani M; Provinciali M; Scotti S; Concetti A Vaccine; 2010 May; 28(22):3841-7. PubMed ID: 20350624 [TBL] [Abstract][Full Text] [Related]
17. Local delivery of recombinant vaccinia virus encoding for neu counteracts growth of mammary tumors more efficiently than systemic delivery in neu transgenic mice. Masuelli L; Marzocchella L; Focaccetti C; Lista F; Nardi A; Scardino A; Mattei M; Turriziani M; Modesti M; Forni G; Schlom J; Modesti A; Bei R Cancer Immunol Immunother; 2010 Aug; 59(8):1247-58. PubMed ID: 20364378 [TBL] [Abstract][Full Text] [Related]
18. A limited autoimmunity to p185neu elicited by DNA and allogeneic cell vaccine hampers the progression of preneoplastic lesions in HER-2/NEU transgenic mice. Lo Iacono M; Cavallo F; Quaglino E; Rolla S; Iezzi M; Pupa SM; De Giovanni C; Lollini PL; Musiani P; Forni G; Calogero RA Int J Immunopathol Pharmacol; 2005; 18(2):351-63. PubMed ID: 15888257 [TBL] [Abstract][Full Text] [Related]
19. Intramammary application of non-methylated-CpG oligodeoxynucleotides (CpG) inhibits both local and systemic mammary carcinogenesis in female BALB/c Her-2/neu transgenic mice. Mastini C; Becker PD; Iezzi M; Curcio C; Musiani P; Forni G; Cavallo F; Guzmán CA Curr Cancer Drug Targets; 2008 May; 8(3):230-42. PubMed ID: 18473736 [TBL] [Abstract][Full Text] [Related]
20. Immunoprevention of mammary carcinoma in HER-2/neu transgenic mice is IFN-gamma and B cell dependent. Nanni P; Landuzzi L; Nicoletti G; De Giovanni C; Rossi I; Croci S; Astolfi A; Iezzi M; Di Carlo E; Musiani P; Forni G; Lollini PL J Immunol; 2004 Aug; 173(4):2288-96. PubMed ID: 15294941 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]